Mehrdad Ghorbani Rad
YOU?
Author Swipe
View article: Comparison of Accuracy in Calculation of Absorbed Dose to the Kidneys Following Radioligand Therapy with 177Lu-DKFZ-PSMA-617 by Two Different Background Correction Methods
Comparison of Accuracy in Calculation of Absorbed Dose to the Kidneys Following Radioligand Therapy with 177Lu-DKFZ-PSMA-617 by Two Different Background Correction Methods Open
Background: To improve the accuracy of activity image quality, scatter correction is a critical method. The aim of this study is to compare the accuracy in calculation of absorbed dose to patients following radioligand therapy (RLT) with 1…
View article: External dose assessment from the patients treated by 177Lu-DOTATATE
External dose assessment from the patients treated by 177Lu-DOTATATE Open
Background: The present study was done to establish release criterion in the treated patients and to determine external radiation doses received by personnel and caregivers of patients with metastatic neuroendocrine tumors (NETs) during pe…
View article: Radiation Dose to Medical Staff from Administering<sup>177</sup>Lu-PSMA-DKFZ-617 Therapy
Radiation Dose to Medical Staff from Administering<sup>177</sup>Lu-PSMA-DKFZ-617 Therapy Open
The number of radioligand therapy applications for metastatic castration-resistant prostate cancer has been continuously rising in most nuclear medicine departments in Iran, but to our knowledge, no one has studied the dose to staff who pe…
View article: Patient-Specific Dosimetry in Radioligand Therapy (RLT) for Metastatic Prostate Cancer Using 177Lu-DKFZ-PSMA-617
Patient-Specific Dosimetry in Radioligand Therapy (RLT) for Metastatic Prostate Cancer Using 177Lu-DKFZ-PSMA-617 Open